Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081.
JAMA. 2015.
PMID: 26325557
Clinical Trial.
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.
Ruilope LM, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Ferreira AC, Pieper A, Kimmeskamp-Kirschbaum N, Bakris GL.
Ruilope LM, et al. Among authors: kimmeskamp kirschbaum n.
Am J Nephrol. 2014;40(6):572-81. doi: 10.1159/000371497. Epub 2015 Jan 10.
Am J Nephrol. 2014.
PMID: 25591469
Clinical Trial.
Item in Clipboard
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.
Filippatos G, Anker SD, Böhm M, Gheorghiade M, Køber L, Krum H, Maggioni AP, Ponikowski P, Voors AA, Zannad F, Kim SY, Nowack C, Palombo G, Kolkhof P, Kimmeskamp-Kirschbaum N, Pieper A, Pitt B.
Filippatos G, et al. Among authors: kimmeskamp kirschbaum n.
Eur Heart J. 2016 Jul 14;37(27):2105-14. doi: 10.1093/eurheartj/ehw132. Epub 2016 Apr 29.
Eur Heart J. 2016.
PMID: 27130705
Free PMC article.
Clinical Trial.
Item in Clipboard
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.
Pitt B, Anker SD, Böhm M, Gheorghiade M, Køber L, Krum H, Maggioni AP, Ponikowski P, Voors AA, Zannad F, Nowack C, Kim SY, Pieper A, Kimmeskamp-Kirschbaum N, Filippatos G.
Pitt B, et al. Among authors: kimmeskamp kirschbaum n.
Eur J Heart Fail. 2015 Feb;17(2):224-32. doi: 10.1002/ejhf.218.
Eur J Heart Fail. 2015.
PMID: 25678098
Free article.
Clinical Trial.
Item in Clipboard
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94-8862) in Individuals With Renal Impairment.
Heinig R, Kimmeskamp-Kirschbaum N, Halabi A, Lentini S.
Heinig R, et al. Among authors: kimmeskamp kirschbaum n.
Clin Pharmacol Drug Dev. 2016 Nov;5(6):488-501. doi: 10.1002/cpdd.263. Epub 2016 Jul 18.
Clin Pharmacol Drug Dev. 2016.
PMID: 27431783
Item in Clipboard
Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone - results from first-in-man and relative bioavailability studies.
Lentini S, Heinig R, Kimmeskamp-Kirschbaum N, Wensing G.
Lentini S, et al. Among authors: kimmeskamp kirschbaum n.
Fundam Clin Pharmacol. 2016 Apr;30(2):172-84. doi: 10.1111/fcp.12170. Epub 2016 Jan 14.
Fundam Clin Pharmacol. 2016.
PMID: 26604072
Item in Clipboard
Cite
Cite